AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Doxorubicin Hydrochloride in South Africa
26 products registered with SAHPRA — 17 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| DOXRED 10 LYOPHILIZED POWDER | 57/26/0698 | Oethmaan Biosims (Pty) Ltd | active | 20 Feb 2029 |
| DOXRED 50 LYOPHILIZED POWDER | 57/26/0699 | Oethmaan Biosims (Pty) Ltd | active | 20 Feb 2029 |
| ADRIBLASTINA CSV 10 mg/5 ml | 33/26/0102 | Pfizer Laboratories (Pty) Ltd | suspended | 23 Feb 2024 |
| ADRIBLASTINA CSV 50 mg/25 ml | 33/26/0104 | Pfizer Laboratories (Pty) Ltd | suspended | 23 Feb 2024 |
| ADRIBLASTINA RD 50 mg | F/26/289 | Pfizer Laboratories (Pty) Ltd | suspended | 23 Feb 2024 |
| ADRIBLASTINA RD 10 mg | F/26/274 | Pfizer Laboratories (Pty) Ltd | suspended | 23 Feb 2024 |
| ADRIBLASTINA RD 20 mg | U/26/183 | Pfizer Laboratories (Pty) Ltd | suspended | 23 Feb 2024 |
| DOXORUBICIN HCL-FAULDING 50 mg | 29/26/0673 | Pfizer Laboratories (Pty) Ltd | suspended | 20 Feb 2024 |
| DOXORUBICIN HCL-FAULDING 10 mg | 29/26/0672 | Pfizer Laboratories (Pty) Ltd | suspended | 20 Feb 2024 |
| DOXORUBICIN "EBEWE" 10 mg | A40/26/0352 | Key Oncologics (Pty) Ltd | suspended | 6 Jul 2022 |
| DOXORUBICIN "EBEWE" 50 mg | A40/26/0353 | Key Oncologics (Pty) Ltd | suspended | 6 Jul 2022 |
| BIO-DOXORUBICIN HYDROCHLORIDE 10 | 32/26/0507 | Zimbili Pharma cc | active | 25 Oct 2006 |
| RUBEXET 200 mg/100 ml | 46/26/0489 | Accord Healthcare (Pty) Ltd | active | 1 Jan 1900 |
| CIPLA-DOXORUBICIN 50 | 41/26/0035 | Cipla Medpro (Pty) Ltd | active | 1 Jan 1900 |
| BIO-DOXORUBICIN HYDROCHLORIDE 50 | 32/26/0508 | Zimbili Pharma cc | active | 1 Jan 1900 |
| CIPLA-DOXORUBICIN 10 | 41/26/0034 | Cipla Medpro (Pty) Ltd | active | 1 Jan 1900 |
| RUBEXET 50 mg/25 ml | 46/26/0488 | Accord Healthcare (Pty) Ltd | active | 1 Jan 1900 |
| DOXORUBICIN ACCORD 50 mg/25 ml | 46/26/0485 | Accord Healthcare (Pty) Ltd | active | 1 Jan 1900 |
| RUBEXET 10 mg/5 ml | 46/26/0487 | Accord Healthcare (Pty) Ltd | active | 1 Jan 1900 |
| DOXORUBICIN-SOL PCH 10 mg | Z/26/167 | Teva Pharmaceuticals (Pty) Ltd | active | 1 Jan 1900 |
| DOXORUBICIN-SOL PCH 50 mg | Z/26/169 | Teva Pharmaceuticals (Pty) Ltd | active | 1 Jan 1900 |
| DOXORUBICIN-SOL PCH 200 mg | Z/26/170 | Teva Pharmaceuticals (Pty) Ltd | active | 1 Jan 1900 |
| CAELYX | 32/26/0533 | Baxter Healthcare South Africa (Pty) Ltd | active | 1 Jan 1900 |
| HX-DOXORUBICIN 10 mg/ 5 ml | 37/26/0030 | Oethmaan Biosims (Pty) Ltd | active | 1 Jan 1900 |
| HX-DOXORUBICIN 50 mg/ 25 ML | 37/26/0031 | Oethmaan Biosims (Pty) Ltd | active | 1 Jan 1900 |
| DOXOPEG | A40/26/0389 | Key Oncologics (Pty) Ltd | active | 1 Jan 1900 |
Doxorubicin Hydrochloride — SAHPRA Registration Details
SAHPRA (South Africa) has 26 registered products containing Doxorubicin Hydrochloride, of which 17 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Doxorubicin Hydrochloride registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.